BARBARINO, MARCELLA
BARBARINO, MARCELLA
Dipartimento di Biotecnologie Mediche
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
2022-01-01 Dell'Anno, Irene; Melani, Alessandra; Martin, Sarah A; Barbarino, Marcella; Silvestri, Roberto; Cipollini, Monica; Giordano, Antonio; Mutti, Luciano; Nicolini, Andrea; Luzzi, Luca; Aiello, Raffaele; Gemignani, Federica; Landi, Stefano
Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology
2022-01-01 Barbarino, M.; Bottaro, M.; Spagnoletti, L.; de Santi, M. M.; Guazzo, R.; Defraia, C.; Custoza, C.; Serio, G.; Iannelli, F.; Pesetti, M.; Aiello, R.; Rosati, D.; Zanfrini, E.; Luzzi, L.; Bellan, C.; Giordano, A.
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
2017-01-01 Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo
Assessment of the carcinogenicity of carbon nanotubes in the respiratory system
2021-01-01 Barbarino, M.; Giordano, A.
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy
2021-01-01 Nardone, V.; Barbarino, M.; Angrisani, A.; Correale, P.; Pastina, P.; Cappabianca, S.; Reginelli, A.; Mutti, L.; Miracco, C.; Giannicola, R.; Giordano, A.; Pirtoli, L.
CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway
2002-01-01 Graziani, G; Tentori, L; Portarena, I; Barbarino, M; Tringali, G; Pozzoli, G; Navarra, P.
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells
2003-01-01 Di Gennaro, E; Barbarino, M; Bruzzese, F; De Lorenzo, S; Caraglia, M; Abbruzzese, A; Avallone, A; Comella, P; Caponigro, F; Pepe, S; Budillon, A
Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
2009-01-01 Dallavalle, S; Cincinelli, R; Nannei, R; Merlini, L; Morini, G; Penco, S; Pisano, C; Vesci, L; Barbarino, M; Zuco, V; De Cesare, M; Zunino, F.
Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response
2005-01-01 Zuco, V; Zanchi, C; Lanzi, C; Beretta, Gl; Supino, R; Pisano, C; Barbarino, M; Zanier, R; Bucci, F; Aulicino, C; Carminati, P; Zunino, F.
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
2021-01-01 Dell'Anno, I.; Martin, S. A.; Barbarino, M.; Melani, A.; Silvestri, R.; Bottaro, M.; Paolicchi, E.; Corrado, A.; Cipollini, M.; Melaiu, O.; Giordano, A.; Luzzi, L.; Gemignani, F.; Landi, S.
Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells
2018-01-01 Damiano, Sara; Montagnaro, Serena; Puzio, Maria Valeria; Severino, Lorella; Pagnini, Ugo; Barbarino, Marcella; Cesari, Daniele; Giordano, Antonio; Florio, Salvatore; Ciarcia, Roberto
Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry
2011-01-01 Badaloni, E; Barbarino, M; Cabri, W; D'Acquarica, I; Forte, M; Gasparrini, F; Giorgi, F; Pierini, M; Simone, P; Ursini, O; Villani, C.
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma
2020-01-01 Dell'Anno, I.; Barbarino, M.; Barone, E.; Giordano, A.; Luzzi, L.; Bottaro, M.; Migliore, L.; Agostini, S.; Melani, A.; Melaiu, O.; Catalano, C.; Cipollini, M.; Silvestri, R.; Corrado, A.; Gemignani, F.; Landi, S.
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes
2021-01-01 Cheleschi, S.; Tenti, S.; Barbarino, M.; Giannotti, S.; Bellisai, F.; Frati, E.; Fioravanti, A.
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
2017-01-01 Cimini, Annamaria; D’Angelo, Michele; Benedetti, Elisabetta; D’Angelo, Barbara; Laurenti, Giulio; Antonosante, Andrea; Cristiano, Loredana; Di Mambro, Antonella; Barbarino, Marcella; Castelli, Vanessa; Cinque, Benedetta; Cifone, Maria Grazia; Ippoliti, Rodolfo; Pentimalli, Francesca; Giordano, Antonio
Hydrostatic pressure regulates oxidative stress through microRNA in human osteoarthritic chondrocytes
2020-01-01 Cheleschi, S.; Barbarino, M.; Gallo, I.; Tenti, S.; Bottaro, M.; Frati, E.; Giannotti, S.; Fioravanti, A.
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab
2017-01-01 Pastina, Pierpaolo; Nardone, Valerio; Battaglia, Giuseppe; Botta, Cirino; Tini, Paolo; Bellan, Cristiana; Ricci, Veronica; Barbarino, Marcella; Croci, Stefania; Caraglia, Michele; Giordano, Antonio; Cusi, MARIA GRAZIA; Pirtoli, Luigi; Pierpaolo, Correale
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (ADP-ribose) polymerase inhibitor
2003-01-01 Tentori, L.; Portarena, I.; Barbarino, M.; Balduzzi, A.; Levati, L.; Vergati, M.; Biroccio, A.; Gold, B.; Lombardi, M. L.; Graziani, G.
Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors
2012-01-01 Bargiotti, A; Musso, L; Dallavalle, S; Merlini, L; Gallo, G; Ciacci, A; Giannini, G; Cabri, W; Penco, S; Vesci, L; Castorina, M; Milazzo, Fm; Cervoni, Ml; Barbarino, M; Pisano, C; Giommarelli, C; Zuco, V; De,
Mesothelioma malignancy and the microenvironment: Molecular mechanisms
2021-01-01 Cersosimo, F.; Barbarino, M.; Lonardi, S.; Vermi, W.; Giordano, A.; Bellan, C.; Giurisato, E.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma | 1-gen-2022 | Dell'Anno, Irene; Melani, Alessandra; Martin, Sarah A; Barbarino, Marcella; Silvestri, Roberto; Cipollini, Monica; Giordano, Antonio; Mutti, Luciano; Nicolini, Andrea; Luzzi, Luca; Aiello, Raffaele; Gemignani, Federica; Landi, Stefano | - | |
| Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology | 1-gen-2022 | Barbarino, M.; Bottaro, M.; Spagnoletti, L.; de Santi, M. M.; Guazzo, R.; Defraia, C.; Custoza, C.; Serio, G.; Iannelli, F.; Pesetti, M.; Aiello, R.; Rosati, D.; Zanfrini, E.; Luzzi, L.; Bellan, C.; Giordano, A. | - | |
| Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo | - | |
| Assessment of the carcinogenicity of carbon nanotubes in the respiratory system | 1-gen-2021 | Barbarino, M.; Giordano, A. | - | |
| CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy | 1-gen-2021 | Nardone, V.; Barbarino, M.; Angrisani, A.; Correale, P.; Pastina, P.; Cappabianca, S.; Reginelli, A.; Mutti, L.; Miracco, C.; Giannicola, R.; Giordano, A.; Pirtoli, L. | - | |
| CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway | 1-gen-2002 | Graziani, G; Tentori, L; Portarena, I; Barbarino, M; Tringali, G; Pozzoli, G; Navarra, P. | - | |
| Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells | 1-gen-2003 | Di Gennaro, E; Barbarino, M; Bruzzese, F; De Lorenzo, S; Caraglia, M; Abbruzzese, A; Avallone, A; Comella, P; Caponigro, F; Pepe, S; Budillon, A | - | |
| Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors | 1-gen-2009 | Dallavalle, S; Cincinelli, R; Nannei, R; Merlini, L; Morini, G; Penco, S; Pisano, C; Vesci, L; Barbarino, M; Zuco, V; De Cesare, M; Zunino, F. | - | |
| Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response | 1-gen-2005 | Zuco, V; Zanchi, C; Lanzi, C; Beretta, Gl; Supino, R; Pisano, C; Barbarino, M; Zanier, R; Bucci, F; Aulicino, C; Carminati, P; Zunino, F. | - | |
| Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma | 1-gen-2021 | Dell'Anno, I.; Martin, S. A.; Barbarino, M.; Melani, A.; Silvestri, R.; Bottaro, M.; Paolicchi, E.; Corrado, A.; Cipollini, M.; Melaiu, O.; Giordano, A.; Luzzi, L.; Gemignani, F.; Landi, S. | - | |
| Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells | 1-gen-2018 | Damiano, Sara; Montagnaro, Serena; Puzio, Maria Valeria; Severino, Lorella; Pagnini, Ugo; Barbarino, Marcella; Cesari, Daniele; Giordano, Antonio; Florio, Salvatore; Ciarcia, Roberto | - | |
| Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry | 1-gen-2011 | Badaloni, E; Barbarino, M; Cabri, W; D'Acquarica, I; Forte, M; Gasparrini, F; Giorgi, F; Pierini, M; Simone, P; Ursini, O; Villani, C. | - | |
| Eif4g1 and ran as possible drivers for malignant pleural mesothelioma | 1-gen-2020 | Dell'Anno, I.; Barbarino, M.; Barone, E.; Giordano, A.; Luzzi, L.; Bottaro, M.; Migliore, L.; Agostini, S.; Melani, A.; Melaiu, O.; Catalano, C.; Cipollini, M.; Silvestri, R.; Corrado, A.; Gemignani, F.; Landi, S. | - | |
| Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes | 1-gen-2021 | Cheleschi, S.; Tenti, S.; Barbarino, M.; Giannotti, S.; Bellisai, F.; Frati, E.; Fioravanti, A. | - | |
| Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs | 1-gen-2017 | Cimini, Annamaria; D’Angelo, Michele; Benedetti, Elisabetta; D’Angelo, Barbara; Laurenti, Giulio; Antonosante, Andrea; Cristiano, Loredana; Di Mambro, Antonella; Barbarino, Marcella; Castelli, Vanessa; Cinque, Benedetta; Cifone, Maria Grazia; Ippoliti, Rodolfo; Pentimalli, Francesca; Giordano, Antonio | - | |
| Hydrostatic pressure regulates oxidative stress through microRNA in human osteoarthritic chondrocytes | 1-gen-2020 | Cheleschi, S.; Barbarino, M.; Gallo, I.; Tenti, S.; Bottaro, M.; Frati, E.; Giannotti, S.; Fioravanti, A. | - | |
| Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Battaglia, Giuseppe; Botta, Cirino; Tini, Paolo; Bellan, Cristiana; Ricci, Veronica; Barbarino, Marcella; Croci, Stefania; Caraglia, Michele; Giordano, Antonio; Cusi, MARIA GRAZIA; Pirtoli, Luigi; Pierpaolo, Correale | - | |
| Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (ADP-ribose) polymerase inhibitor | 1-gen-2003 | Tentori, L.; Portarena, I.; Barbarino, M.; Balduzzi, A.; Levati, L.; Vergati, M.; Biroccio, A.; Gold, B.; Lombardi, M. L.; Graziani, G. | - | |
| Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors | 1-gen-2012 | Bargiotti, A; Musso, L; Dallavalle, S; Merlini, L; Gallo, G; Ciacci, A; Giannini, G; Cabri, W; Penco, S; Vesci, L; Castorina, M; Milazzo, Fm; Cervoni, Ml; Barbarino, M; Pisano, C; Giommarelli, C; Zuco, V; De, | - | |
| Mesothelioma malignancy and the microenvironment: Molecular mechanisms | 1-gen-2021 | Cersosimo, F.; Barbarino, M.; Lonardi, S.; Vermi, W.; Giordano, A.; Bellan, C.; Giurisato, E. | - |